Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2024

02.10.2023 | Oculoplastics and Orbit

Comparison of the clinical characteristics of benign and malignant eyelid lesions: an analysis of 1423 eyelid lesions, compared between ophthalmology department and plastics department

verfasst von: Oz Levinkron, Liat Schwalb, Aziz Shoufani, Joel Gutovitz, Judit Krausz, Daniel Briscoe

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Oculoplastic surgeons excise and reconstruct eyelid tumors, although plastic surgeons have traditionally managed these cases. Current demand of this surgery is growing, and planning referral services is a health management necessity. This pilot study retrospectively reviewed same population eyelid specimens excised by both disciplines comparing data.

Methods

Clinical and epidemiologic features of 1423 eyelid lesions biopsied between 2015- 2020 in Emek Medical Center (EMC), Israel were reviewed.

Results

Among 1423 specimens, 1210 (85.0%) were benign and 213 (15.0%) were malignant/pre-malignant. Mean age at diagnosis was significantly higher in malignant tumors than in benign tumors (76 and 59 years respectively, p value < 0.001). The most common benign eyelid lesions were soft fibroma (20.1%), seborrheic keratosis (11.0%) and melanocytic nevus (10.3%). The most common malignant/pre-malignant eyelid tumors were basal cell carcinoma (BCC) (9.2%), actinic keratosis (2.6%) and Bowen’s disease (1.9%). Ophthalmology removed 37 malignant/pre-malignant lesions (5.4%) out of 683 compared to plastics removing 142 malignant/pre-malignant lesions out of 740 (19.2%) specimens. Eyelid malignancy in the plastics department was significantly higher than in the ophthalmology department (p value < 0.001). 270 (70.0%) lesions caused by UV exposure were removed by plastics and 116 (30.0%) were removed by ophthalmology (p value < 0.001).

Conclusions

Eyelid lesions in patients aged 76 or older are more likely to be malignant. Ophthalmology eyelid specimens in younger patients are more commonly benign and related to inflammation. Specimens from the plastics department are more commonly malignant, related to UV-exposure, and are from older patients. This difference may be due to a misconception that plastic surgeons have more eyelid cancer reconstruction experience than oculoplastic surgeons, or less awareness of the oculoplastic expertise available today.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Huang YY, Liang WY, Tsai CC et al (2015) Comparison of the clinical characteristics and outcome of benign and malignant eyelid tumors: an analysis of 4521 eyelid tumors in a tertiary medical Center. Biomed Res Int 2015:453091CrossRefPubMedPubMedCentral Huang YY, Liang WY, Tsai CC et al (2015) Comparison of the clinical characteristics and outcome of benign and malignant eyelid tumors: an analysis of 4521 eyelid tumors in a tertiary medical Center. Biomed Res Int 2015:453091CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Cook BE Jr, Bartley GB (1999) Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology 106:746–750CrossRefPubMed Cook BE Jr, Bartley GB (1999) Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology 106:746–750CrossRefPubMed
3.
Zurück zum Zitat Deprez M, Uffer S (2009) Clinicopathological features of eyelid skin tumors. a retrospective study of 5504 cases and review of literature. Am J Dermatopathol 31:256–262CrossRefPubMed Deprez M, Uffer S (2009) Clinicopathological features of eyelid skin tumors. a retrospective study of 5504 cases and review of literature. Am J Dermatopathol 31:256–262CrossRefPubMed
4.
Zurück zum Zitat Gundogan FC, Yolcu U, Tas A et al (2015) Eyelid tumors: clinical data from an eye center in Ankara, Turkey. Asian Pac J Cancer Prev 16:4265–4269CrossRefPubMed Gundogan FC, Yolcu U, Tas A et al (2015) Eyelid tumors: clinical data from an eye center in Ankara, Turkey. Asian Pac J Cancer Prev 16:4265–4269CrossRefPubMed
5.
Zurück zum Zitat Yu SS, Zhao Y, Zhao H, Lin JY, Tang X (2018) A retrospective study of 2228 cases with eyelid tumors. Int J Ophthalmol 11:1835–1841PubMedPubMedCentral Yu SS, Zhao Y, Zhao H, Lin JY, Tang X (2018) A retrospective study of 2228 cases with eyelid tumors. Int J Ophthalmol 11:1835–1841PubMedPubMedCentral
6.
Zurück zum Zitat Asproudis I, Sotiropoulos G, Gartzios C et al (2015) Eyelid tumors at the university eye clinic of Ioannina, Greece: a 30-year retrospective study. Middle East Afr J Ophthalmol 22:230–232CrossRefPubMedPubMedCentral Asproudis I, Sotiropoulos G, Gartzios C et al (2015) Eyelid tumors at the university eye clinic of Ioannina, Greece: a 30-year retrospective study. Middle East Afr J Ophthalmol 22:230–232CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ho M, Lio DT, Chong KK, Ng HK, Lam DS (2013) Eyelid tumours and pseudotumours in Hong Kong: a ten-year experience. Hong Kong Med J 19:150–155PubMed Ho M, Lio DT, Chong KK, Ng HK, Lam DS (2013) Eyelid tumours and pseudotumours in Hong Kong: a ten-year experience. Hong Kong Med J 19:150–155PubMed
Metadaten
Titel
Comparison of the clinical characteristics of benign and malignant eyelid lesions: an analysis of 1423 eyelid lesions, compared between ophthalmology department and plastics department
verfasst von
Oz Levinkron
Liat Schwalb
Aziz Shoufani
Joel Gutovitz
Judit Krausz
Daniel Briscoe
Publikationsdatum
02.10.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2024
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-023-06244-5

Weitere Artikel der Ausgabe 2/2024

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2024 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.